Dr. Joel Michael Corwin, MD

Dr. Corwin practices at Miramar Eye Specialists Medical Group in Ventura, California.

Dr. Corwin's NPI, 1518901651, was assigned on June 16, 2006. Dr. Corwin graduated from The Warren Alpert Medical School of Brown University in 1978. Dr. Corwin holds California license G49477.

Dr. Corwin's primary practice is Miramar Eye Specialists Medical Group, at 3085 Loma Vista Rd, Ventura, CA 93003 in Ventura County. The practice phone is (805) 648-3085.

Dr. Corwin's primary practice is Miramar Eye Specialists Medical Group in Ventura, California. Dmand AI also links Dr. Corwin to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Corwin practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Corwin's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Corwin is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Corwin is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, dry eye, eyelid inflammation, glaucoma, hypertensive retinopathy and inflammation of iris among the conditions Dr. Corwin treats.

CMS data shows 10,394 Medicare services from Dr. Corwin across 12 procedure codes in 2024, for 1,272 Medicare patients. Medicare paid $1,080,513 for them. Every service was in an office.

CMS counts 1,272 Medicare patients who saw Dr. Corwin in 2024. The largest group is 75 to 84, with 503 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Corwin's median patient age at 74, with 52% women.

In 2024, Dr. Corwin wrote 557 Medicare Part D claims for 145 patients. 54% of them were for generic drugs. CMS names the drug for 470 of them, across 12 drugs with 11 or more claims each, at $33,551 in total drug cost. In 2023, CMS named 593 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Corwin for performance year 2024, reported as part of a group. Dr. Corwin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of cataract surgery by Dr. Corwin, more than 32% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Corwin.

CMS Open Payments shows 191 general payments to Dr. Corwin from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Alcon Laboratories Inc paid the most, $2,149.

Dmand AI lists 1 award for Dr. Corwin.

Dr. Corwin graduated from The Warren Alpert Medical School of Brown University in 1978. Dr. Corwin is a member of AAO.

Dr. Corwin is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.